Mitrev, N., Vande Casteele, N., Corte, C., Ghaly, S., Lemberg, D. A., Kariyawasam, V., Lewindon, P., Martin, J., Mountifield, R., Radford-Smith, G., Slobodian, P., Sparrow, M., Seow, C. H., , , , , , Andrews, J. M., Connor, S. J., Moore, G. T., Barclay, M., Begun, J., Bryant, R., Chan, W.. Wiley-Blackwell; 2017. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Marks, E., Naudin, C., Callister, R., Veysey, M., Walker, M. M., Talley, N. J., Radford-Smith, G., Keely, S., Nolan, G., Goggins, B. J., Burns, G., Mateer, S. W., Latimore, J. K., Minahan, K., Plank, M., Foster, P. S.. Nature Publishing Group; 2017. Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.